Colchicine Tablet
Product Images NDC 70710-1571

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Colchicine (NDC 70710-1571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E45c3bc2 D6d2 4bf3 934a 164c6a46f317 01

The image shows a formula for estimating creatinine clearance (Clcr), which includes variables for age in years, weight in kilograms, serum creatinine in mg/dL, and a factor adjustment for female patients. This formula relates to pharmacokinetic considerations for the drug Colchicine tablets.*

FDA Label Image

E45c3bc2 D6d2 4bf3 934a 164c6a46f317 02

Chemical structure diagram of Colchicine showing the arrangement of atoms and chemical bonds, including methoxy groups and a carbonyl functional group, representing the active ingredient Colchicine.*

FDA Label Image

E45c3bc2 D6d2 4bf3 934a 164c6a46f317 03

Colchicine Tablets, USP 0.3 mg oral tablets label by Zydus Pharmaceuticals USA Inc. The label indicates a 30-tablet package with prescription only designation. It includes storage instructions, child resistant packaging note, and manufacturer information for Cadila Healthcare Ltd., India. The label also features an NDC number 70710-1571-3 and a barcode.*

FDA Label Image

E45c3bc2 D6d2 4bf3 934a 164c6a46f317 04

Colchicine Tablets, USP 0.6 mg oral film-coated tablets in a package of 30 tablets. The label shows the NDC number 70710-1351-3 and instructs pharmacists to dispense the medication guide separately. It is manufactured by Cadila Healthcare Ltd. and distributed by Zydus Pharmaceuticals USA Inc. The label includes storage instructions and warnings for child resistance and keeping the medication out of reach of children.*

FDA Label Image

E45c3bc2 D6d2 4bf3 934a 164c6a46f317 05

A line graph comparing the percentage of patients improved against the percentage improvement for Colchicine low-dose (1.8 mg), high-dose (4.8 mg), and placebo groups. The graph shows three lines representing patient improvement rates across different improvement thresholds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.